Category: District of Delaware
-
Moderna, Genevant, Arbutus settle global mRNA patent infringement dispute
Moderna could have to pay up to $2.25 billion as part of the settlement agreement, but remains confident it will close 2026 with up to $5 billion in cash and cash equivalents as a result of the deal.
-
BREAKING: Ericsson brings declaratory judgment action against Acer over 4G/5G patents in District of Delaware to protect its customers
As part of its wider dispute with Nokia, Acer threatened and ultimately sued U.S. mobile network operators over 4G/5G patents. But Ericsson sells equipment to the same customers and is now trying to protect them.
-
Astellas settles parallel bladder treatment patent suits against India’s Lupin, Zydus: licensing deals worth combined $210 million
Japanese pharmaceutical giant Astellas has signed patent licensing agreements with Indian rivals Lupin and Zydus worth over $210 million, ending all ongoing litigation between the companies in the District of Delaware.
-
Novo Nordisk files fresh semaglutide patent infringement suit in District of Delaware
Novo Nordisk has sued telehealth medication provider Hims & Hers over the infringement of one of its semaglutide patents, as the company faces headwinds over its weightloss drugs for the first time in nearly a decade.
-
Lenovo settles long-running U.S. USB-C patent infringement dispute
Lenovo and IT and cloud communications firm Universal Connectivity Technologies have settled a three-year patent infringement dispute that spanned the Eastern District of Texas, the District of Delaware, and the United States Patent and Trademark Office’s Patent Trial and Appeal Board.
-
Edwards faces heart valve patent infringement suit in District of Delaware
Edwards Lifesciences, an active enforcer of its heart valve technology patents in the Unified Patent Court, is now finding itself on the defending side of a patent infringement suit, filed by Israel-based rival Cardiovalve in the U.S.
-
Bayer adds to COVID patent wars: sues Pfizer/BioNTech, Moderna, J&J over mRNA technologyÂ
Bayer’s Monsanto has sued Pfizer/BioNTech, Moderna, and Johnson & Johnson over the alleged infringement of a patent related to gene sequencing technology through their COVID-19 vaccinations.
-
Some direct patent infringement “acceptable price” for expediting competition: U.S. Solicitor General urges Supreme Court to review skinny labeling and generic drug access
United States Solicitor General D. John Sauer has filed a petition urging the Supreme Court to intervene in a long-running drug patent infringement case in which he alleges the Federal Circuit failed to apply the “skinny labelling” (section viii) pathway, which allows the entry of generics that carve out patented uses but otherwise duplicate the…
-
The Federal Circuit wants a district court to provide clarity about the scope of a ruling by a judge who has meanwhile been appointed to the Federal Circuit
The circuit judges can’t just knock at the door of their colleague and ask him what he meant a few years ago. They need something formal from the district court.
-
After Amazon’s pre-emptive UK strike, InterDigital has now launched enforcement actions in U.S., UPC, Germany, Brazil over video patents
“Amazon is more interested in litigating than negotiating,” InterDigital’s Chief Legal Officer Josh Schmidt said in a statement today, as the company gears up for an anti-interim-license injunction hearing in the UPC this Friday.